HIV vaccine development and clinical trials

R. Hoff, J. McNamara, Mary Glenn Fowler, M. McCauley

Research output: Contribution to journalArticle

Abstract

The magnitude of HIV pandemic has made the development of HIV vaccines an urgent biomedical research priority. Although the biologic problems in designing a vaccine for a chronic viral infection like HIV are formidable, there has been encouraging progress. More than a dozen first generation prophylactic HIV vaccine candidates have completed phase I human trials that have established the safety and immunogenicity of these products in adults. A phase II trial of two HIV subunit envelope vaccines in adults at high risk of HIV infection is underway in the United States, and preparations for phase III efficacy trials have begun. Preliminary studies are under way to evaluate the potential application of active and passive immunization for preventing vertical transmission of HIV. Because of the higher rate of HIV transmission and a more abbreviated time course to disease, it may be more efficient to evaluate the efficacy of HIV vaccines in HIV infected pregnant women and their offspring than in adults who are exposed sexually to HIV.

Original languageEnglish (US)
Pages (from-to)73-77
Number of pages5
JournalActa paediatrica (Oslo, Norway : 1992). Supplement
Volume83
Issue number400
StatePublished - 1994
Externally publishedYes

Fingerprint

AIDS Vaccines
Clinical Trials
HIV
Subunit Vaccines
Passive Immunization
Adult Children
Pandemics
Virus Diseases
HIV Infections
Biomedical Research
Pregnant Women
Vaccination
Vaccines
Safety
Research

Keywords

  • clinical trials
  • HIV vaccines
  • human immunodeficiency virus (HIV)
  • immune globulin
  • vertical transmission

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

HIV vaccine development and clinical trials. / Hoff, R.; McNamara, J.; Fowler, Mary Glenn; McCauley, M.

In: Acta paediatrica (Oslo, Norway : 1992). Supplement, Vol. 83, No. 400, 1994, p. 73-77.

Research output: Contribution to journalArticle

Hoff, R, McNamara, J, Fowler, MG & McCauley, M 1994, 'HIV vaccine development and clinical trials', Acta paediatrica (Oslo, Norway : 1992). Supplement, vol. 83, no. 400, pp. 73-77.
Hoff, R. ; McNamara, J. ; Fowler, Mary Glenn ; McCauley, M. / HIV vaccine development and clinical trials. In: Acta paediatrica (Oslo, Norway : 1992). Supplement. 1994 ; Vol. 83, No. 400. pp. 73-77.
@article{3bd626d9166842c6b0c7a7e4cd03ed95,
title = "HIV vaccine development and clinical trials",
abstract = "The magnitude of HIV pandemic has made the development of HIV vaccines an urgent biomedical research priority. Although the biologic problems in designing a vaccine for a chronic viral infection like HIV are formidable, there has been encouraging progress. More than a dozen first generation prophylactic HIV vaccine candidates have completed phase I human trials that have established the safety and immunogenicity of these products in adults. A phase II trial of two HIV subunit envelope vaccines in adults at high risk of HIV infection is underway in the United States, and preparations for phase III efficacy trials have begun. Preliminary studies are under way to evaluate the potential application of active and passive immunization for preventing vertical transmission of HIV. Because of the higher rate of HIV transmission and a more abbreviated time course to disease, it may be more efficient to evaluate the efficacy of HIV vaccines in HIV infected pregnant women and their offspring than in adults who are exposed sexually to HIV.",
keywords = "clinical trials, HIV vaccines, human immunodeficiency virus (HIV), immune globulin, vertical transmission",
author = "R. Hoff and J. McNamara and Fowler, {Mary Glenn} and M. McCauley",
year = "1994",
language = "English (US)",
volume = "83",
pages = "73--77",
journal = "Acta Paediatrica, International Journal of Paediatrics, Supplement",
issn = "0803-5326",
publisher = "Taylor and Francis Ltd.",
number = "400",

}

TY - JOUR

T1 - HIV vaccine development and clinical trials

AU - Hoff, R.

AU - McNamara, J.

AU - Fowler, Mary Glenn

AU - McCauley, M.

PY - 1994

Y1 - 1994

N2 - The magnitude of HIV pandemic has made the development of HIV vaccines an urgent biomedical research priority. Although the biologic problems in designing a vaccine for a chronic viral infection like HIV are formidable, there has been encouraging progress. More than a dozen first generation prophylactic HIV vaccine candidates have completed phase I human trials that have established the safety and immunogenicity of these products in adults. A phase II trial of two HIV subunit envelope vaccines in adults at high risk of HIV infection is underway in the United States, and preparations for phase III efficacy trials have begun. Preliminary studies are under way to evaluate the potential application of active and passive immunization for preventing vertical transmission of HIV. Because of the higher rate of HIV transmission and a more abbreviated time course to disease, it may be more efficient to evaluate the efficacy of HIV vaccines in HIV infected pregnant women and their offspring than in adults who are exposed sexually to HIV.

AB - The magnitude of HIV pandemic has made the development of HIV vaccines an urgent biomedical research priority. Although the biologic problems in designing a vaccine for a chronic viral infection like HIV are formidable, there has been encouraging progress. More than a dozen first generation prophylactic HIV vaccine candidates have completed phase I human trials that have established the safety and immunogenicity of these products in adults. A phase II trial of two HIV subunit envelope vaccines in adults at high risk of HIV infection is underway in the United States, and preparations for phase III efficacy trials have begun. Preliminary studies are under way to evaluate the potential application of active and passive immunization for preventing vertical transmission of HIV. Because of the higher rate of HIV transmission and a more abbreviated time course to disease, it may be more efficient to evaluate the efficacy of HIV vaccines in HIV infected pregnant women and their offspring than in adults who are exposed sexually to HIV.

KW - clinical trials

KW - HIV vaccines

KW - human immunodeficiency virus (HIV)

KW - immune globulin

KW - vertical transmission

UR - http://www.scopus.com/inward/record.url?scp=0028015967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028015967&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 73

EP - 77

JO - Acta Paediatrica, International Journal of Paediatrics, Supplement

JF - Acta Paediatrica, International Journal of Paediatrics, Supplement

SN - 0803-5326

IS - 400

ER -